Delivery Order SPE2DB22D2007-SPE2DB24FJ4LB
Award Date
7/23/24
Potential Completion Date
7/24/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $1,088.01 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 5% patches. The contract has an ultimate completion date of March 19, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a $2,175.99 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Lidocaine 5% patches. The contract has an ultimate completion date of October 17, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle...
The Defense Logistics Agency (DLA) awarded a $1,620.55 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of Lidocaine 5% patches. The contract has an ultimate completion date of September 3, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical and a $750,000 IDC with the Department of...
The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Lidocaine 5% Patches to support federal healthcare programs. The $2,732.06 contract has an ultimate completion date of July 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a broad range of medical commodities to military treatment facilities...
The U.S. Defense Logistics Agency (DLA) awarded a $48,206.78 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4,565,244,013 units of Lidocaine 5% Patch 30S. The contract has an ultimate completion date of July 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these essential medical supplies to support military treatment facilities and federal healthcare programs. The contract award is not designated as a set-aside....
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,709.61 to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of 4,564,340,251 units of Lidocaine 5% Patch 30s, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. The contract has a ceiling value of $1,287.86 and a completion date of May 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the...
The Defense Logistics Agency (DLA) awarded a $2,114.16 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. This contract has no set-aside designation and an ultimate completion date of September 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a comprehensive range...
The U.S. Defense Logistics Agency (DLA) awarded a $24,964.97 firm-fixed-price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the supply of 4,565,535,769 units of Lidocaine 5% Patch 30s. This delivery order does not have a set-aside designation and has an ultimate completion date of August 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by the DLA and other agencies...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,239,630 units of Lidocaine 5% Patches. The $1,097.36 award has a completion date of January 5, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as a prime contractor, has a history of supplying pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support Medical...